Gastrointestinal , Hepatobiliary and Pancreatic Pathology Zinc Supplementation Enhances Hepatic Regeneration by Preserving Hepatocyte Nuclear Factor-4 in Mice Subjected to Long-Term Ethanol Administration
Xinqin Kang,Zhenyuan Song,Craig J. McClain,Y. James Kang,Zhanxiang Zhou
2010-01-01
Abstract:Alcoholic liver disease is associated with sustained liver damage and impaired regeneration, as well as significant zinc deficiency. This study was undertaken to examine whether dietary zinc supplementation could improve liver regeneration by increasing the expression of genes involved in hepatic cellular proliferation in a mouse model of alcoholic liver disease. Adult 129S6 mice fed an ethanol-containing liquid diet for 6 months developed alcoholic liver disease as measured by serum alanine transferase activity and histopathological changes. Zinc supplementation to ethanol-exposed mice enhanced liver regeneration as indicated by increased numbers of proliferation cell nuclear antigen (PCNA)-positive and bromodeoxyuridine (BrdU)-labeled hepatocytes. Zinc-enhanced liver regeneration was associated with an increase in hepatocyte nuclear factor-4 (HNF-4 ), a liver-enriched, zinc-finger transcription factor. Studies using cultured HepG2 cells showed that zinc deficiency suppressed cell proliferation and cell proliferation-related proteins, including hepatocyte growth factor (HGF), insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 1 (IGFBP1), metallothionein (MT), and cyclin D1, as well as HNF-4 . HNF-4 gene silencing inhibited cell proliferation in association with decreased protein levels of IGF-I, IGFBP1, MT, and cyclin D1. The present study provides evidence that zinc supplementation enhances liver regeneration at least in part by HNF-4 through the up-regulation of cell proliferation-related proteins, suggesting that dietary zinc supplementation may have beneficial effects in alcoholic liver disease. (Am J Pathol 2008, 172:916–925; DOI: 10.2353/ajpath.2008.070631) Zinc deficiency is well documented in alcoholic liver disease. Clinical studies showed that alcoholic patients have lowered zinc levels in serum and liver, which is associated with decrease in zinc absorption from the intestine and increase in zinc excretion from the urine. Zinc is well known as one of the most important trace elements in the body. Dietary zinc deficiency is associated with a variety of physiological defects including anorexia, skin lesion, and growth retardation. Mechanistic studies demonstrated that zinc deficiency affects a large number of hepatic genes involved in multiple cellular functions. In particular, zinc deficiency has been shown to down-regulate hepatic gene expression of metallothionein (MT), insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 1 (IGFBP1), and cyclin D1, which are involved in cell proliferation. Although the significance of zinc deficiency in the pathogenesis of alcoholic liver disease has not been fully understood, our previous studies demonstrated that zinc supplementation prevents ethanol exposure-induced liver injury. Zinc supplementation inhibited ethanolinduced oxidative stress in the liver. Zinc also suppressed the hepatotoxicity induced by lipopolysaccharide and tumor necrosis factor, which are critical mediators in alcoholic liver disease. The liver has a remarkable capacity to regenerate in response to injury. However, experimental investigations have demonstrated that the regeneration capacity of liver is impaired after long-term ethanol intake. Clinical studies demonstrated an imbalance between hepatocyte apoptosis and proliferation in alcoholic patients. Chronic ethanol intake suppresses cell growth factors and cell cycle proteins, such as hepatocyte growth factor (HGF) and cyclin D1. Data from alcoholic hepatitis patients also demonstrated a positive correlation between HGF and hepatocyte proliferation and